PosiHealth, Inc.

Lee HY, Cooke CE, Robertson T.  Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.  J Manag Care Pharm 2008;14(3):271-80.

Chan V, Cooke CE.  Pharmacotherapy after myocardial infarction: Disease management versus usual care.  Am J Manag Care 2008;14(6):352-8.

Safeer RS, Cooke CE, Robertson T.  Pharmacy measures to improve medication use through health-literacy principles.  Manag Care Interface 2007:37-41.

Safeer RS, Cooke CE, Keenan J.  The impact of health literacy on cardiovascular disease.  Vasc Health Risk Manag 2006;2(4):457-64.

Cooke CE, Fatodu H.  Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a Medicaid managed care organization. J Manag Care Pharm 2006;12(8):649-55.

Rochester C, Cooke CE.  The Changing Face of Dyslipidemia Therapies. J Pharm Pract 2006;19(2):79-93.

Cooke CE, Bresette JL, Khanna R.  Statin use in American Indians and Alaska Natives with coronary artery disease.  Am J Health-Syst Pharm 2006;63:1717-22.

Cooke CE, Hammerash WJ Jr.  Sex differences in management of dyslipidemia in members with coronary artery disease.  Clin Ther 2006;28:591-9.

Cooke CE, Wong W, Lee H.  Economic impact of sildenafil utilization in a managed care organization.  J Manag Care Pharm  2005;11(8):674-80.

Cho J, Cooke CE, Proveaux W.  A retrospective review of the effect of COX-2 inhibitors on blood pressure change.  Am J Therapeutics 2003;10:311-7.